Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05108064 | Radiomic and Pathomic Study of Pituitary Adenoma Using Machine Learning | unknown | — | 1,000 | Huashan HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT05024383 | Dissecting the Heterogeneity of Oral Cancer Pain | unknown | N/A | 80 | NYU College of DentistryOTHER | 1 | Sep 28, 2022 | clinicaltrials |
| NCT05551767 |
| Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer |
| unknown |
| Phase 2 |
| 120 |
| City Clinical Oncology Hospital No 1OTHER_GOV |
| 1 |
| Sep 23, 2022 |
| clinicaltrials |
| NCT05547971 | Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomics | unknown | — | 800 | Xiangya Hospital of Central South UniversityOTHER | 1 | Sep 21, 2022 | clinicaltrials |
| NCT05519956 | Elective Level Ib Irradiation in Nasopharyngeal Carcinoma Patients Based on the International Guidelines | unknown | Phase 3 | 398 | Fujian Cancer HospitalOTHER_GOV | 0 | Sep 19, 2022 | clinicaltrials |
| NCT04801095 | A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 100 | Wellmarker BioINDUSTRY | 2 | Sep 16, 2022 | clinicaltrials |
| NCT05526040 | Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment Study(HaNIS) | unknown | N/A | 116 | University of MalayaOTHER | 1 | Sep 2, 2022 | clinicaltrials |
| NCT05505318 | Pattern and Surgical Treatment of Parotid Gland Neoplasms | unknown | — | 60 | Sohag UniversityOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT05510609 | Three-dimensional Ultrasonography Thyroid Volume Measurement. | unknown | N/A | 17 | Rigshospitalet, DenmarkOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT04898374 | Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 120 | Kuwait Cancer Control CenterOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT05503914 | Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma | unknown | N/A | 80 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Aug 17, 2022 | clinicaltrials |
| NCT04214353 | PSMA-PET Imaging Before and After ADT in Advanced SDC Patients(ADT-SCAN) | unknown | N/A | 14 | Radboud University Medical CenterOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT05499936 | 68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC) | unknown | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03934827 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour(MICROBIOME) | unknown | Phase 1 | 120 | Imperial College LondonOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT03830242 | Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. | unknown | N/A | 50 | Fifth Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 28, 2022 | clinicaltrials |
| NCT05477992 | Haemorrhage Risk Reduction Using Endovascular Embolisation in Place of Vessel Ligation for Patients Undergoing Transoral Robotic Surgery (HELPR) | unknown | N/A | 10 | Royal Marsden NHS Foundation TrustOTHER | 0 | Jul 28, 2022 | clinicaltrials |
| NCT05476965 | Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma(iCSDeR) | unknown | Phase 2 | 20 | Hubei Cancer HospitalOTHER | 1 | Jul 27, 2022 | clinicaltrials |
| NCT04322695 | A Rehabilitation Education Care Program on Return to Work Among Head and Neck Cancer Survivors | unknown | N/A | 120 | Chang Gung University of Science and TechnologyOTHER | 1 | Jul 22, 2022 | clinicaltrials |
| NCT05421507 | 3D-PCT Combined With CT-guided Radioactive I-125 Seed Implantation in the Treatment of Head and Neck Tumors | unknown | — | 30 | Peking University Third HospitalOTHER | 1 | Jul 20, 2022 | clinicaltrials |
| NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | unknown | Phase 2 | 1,000,000 | Cairo UniversityOTHER | 1 | Jul 13, 2022 | clinicaltrials |
| NCT05448885 | Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma | unknown | Phase 2 | 50 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jul 8, 2022 | clinicaltrials |
| NCT04398056 | Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 22 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2022 | clinicaltrials |
| NCT05037357 | Verification of Harmonization of Plasma Epstein-Barr Virus DNA Measurements | unknown | — | 370 | Sun Yat-sen UniversityOTHER | 1 | Jul 6, 2022 | clinicaltrials |
| NCT05446441 | Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma | unknown | N/A | 634 | Zhejiang Provincial People's HospitalOTHER | 0 | Jul 6, 2022 | clinicaltrials |
| NCT05351762 | Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC | unknown | Phase 2 | 55 | Xijing HospitalOTHER | 0 | Jul 5, 2022 | clinicaltrials |
| NCT03707509 | Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma | unknown | Phase 3 | 263 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Jul 1, 2022 | clinicaltrials |
| NCT05438784 | Application of CAD-CAM Technology in Orbital Bone Reconstruction(CAD-CAM) | unknown | N/A | 34 | Hatem Adel AboelhassanOTHER | 1 | Jun 30, 2022 | clinicaltrials |
| NCT05122221 | CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers | unknown | Phase 1 | 12 | Corregene Biotechnology Co., LtdINDUSTRY | 1 | Jun 28, 2022 | clinicaltrials |
| NCT05432219 | A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma | unknown | N/A | 20 | Eye & ENT Hospital of Fudan UniversityOTHER | 0 | Jun 27, 2022 | clinicaltrials |
| NCT05431764 | Whole-target Consolidation Therapy Under Systemic Therapy for Oligometastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 38 | Sun Yat-sen UniversityOTHER | 1 | Jun 24, 2022 | clinicaltrials |
| NCT04931576 | No Drainage During Transoral Endoscopic Thyroidectomy Vestibular Approach(TOETVA) | unknown | N/A | 600 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Jun 23, 2022 | clinicaltrials |
| NCT05423704 | Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark | unknown | N/A | 63 | Danish Head and Neck Cancer GroupNETWORK | 1 | Jun 21, 2022 | clinicaltrials |
| NCT05420597 | Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma | unknown | Phase 2 | 61 | Fudan UniversityOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05417139 | Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study | unknown | Phase 2 | 43 | Sun Yat-sen UniversityOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT05418517 | Hospital Acquired Pneumonia in Temporary Tracheostomy(HAP) | unknown | — | 193 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Jun 14, 2022 | clinicaltrials |
| NCT04978012 | Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line Chemotherapy | unknown | Phase 2 | 48 | Fudan UniversityOTHER | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05401370 | Role of Methylene Blue in Parotid Surgery | unknown | N/A | 20 | Assiut UniversityOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05396183 | Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies. | unknown | — | 30 | Peking University Third HospitalOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT01846286 | Neuropathic Pain in Head and Neck Cancer | unknown | — | 838 | M.D. Anderson Cancer CenterOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT04955197 | Exfoliated Cytology in Detection of Oral Premalignant and Malignant Lesions | unknown | — | 48 | Cairo UniversityOTHER | 1 | May 25, 2022 | clinicaltrials |
| NCT04963972 | Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery | unknown | N/A | 272 | Lucid Lane, IncINDUSTRY | 1 | May 10, 2022 | clinicaltrials |
| NCT05240911 | Individual Dosing of Levothyroxine After Thyroidectomy | unknown | N/A | 202 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT05350891 | Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC | unknown | Phase 2 | 77 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT03657654 | Voice Outcomes Following Thyroidectomy | unknown | — | 45 | University of VirginiaOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04842994 | Trial on Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery.(ACTION) | unknown | N/A | 448 | Tata Memorial HospitalOTHER_GOV | 1 | May 5, 2022 | clinicaltrials |
| NCT03669432 | To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.(THYRO-RT) | unknown | N/A | 72 | Tata Memorial HospitalOTHER_GOV | 1 | May 2, 2022 | clinicaltrials |
| NCT03854838 | IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. | unknown | Phase 2 | 25 | Sun Yat-sen UniversityOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT04143984 | Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma | unknown | Phase 2 | 146 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Apr 29, 2022 | clinicaltrials |
| NCT02748707 | Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study(ERLO-XIB) | unknown | Phase 2 | 64 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 28, 2022 | clinicaltrials |
| NCT04073784 | Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma. | unknown | Phase 1 | 41 | Sun Yat-sen UniversityOTHER | 1 | Apr 26, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Sep 29, 2022source: clinicaltrials